Since 2006, Akron’s mission has been to provide GMP-compliant materials and services that enable innovators in the development and commercialization of advanced therapies. Along with its line of GMP quality cytokines, growth factors, blood-derived products, and custom media, Akron specializes in the manufacture of custom plasmids and endonucleases to support viral vector and gene editing technologies. Akron’s ancillary product lines are ISO 13485-certified and its newly opened 110,000 sq. ft. manufacturing facility operates in line with FDA 21 CFR Part 11 and Eudralex Vol 4 Annex 11 standards. Akron provides advanced therapy developers the scale, compliance, flexibility, and regulatory support to develop novel technologies from pre-clinical through to commercialization.